METASTATIC EWING SARCOMA
Clinical trials for METASTATIC EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC EWING SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young patients with spreading bone cancer
Disease control OngoingThis trial is testing whether adding two new drugs, irinotecan and regorafenib, to standard chemotherapy works better for young patients with Ewing sarcoma that has spread. It aims to see if this combination helps patients live longer without their cancer returning. The study is …
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for rare bone cancer: major trial tests drug to stop tumor growth
Disease control OngoingThis large, late-stage trial is testing if adding a new drug called ganitumab to standard chemotherapy helps patients with newly diagnosed Ewing sarcoma that has spread. Ganitumab is designed to block a pathway that helps tumor cells grow. The study aims to see if this combinatio…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for teens fighting relapsed bone cancer
Disease control OngoingThis study is testing an oral drug called cabozantinib to see if it can control the growth of two aggressive bone cancers, osteosarcoma and Ewing sarcoma, in young patients whose cancer has returned or spread after standard treatment. The drug works by blocking signals tumors nee…
Matched conditions: METASTATIC EWING SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC